Fernando Pagán

2.8k citations

72 papers · 1.7k · h-index 21

Impact in

Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
- Neuroinflammation and Neurodegeneration Mechanisms
Cellular and Molecular Neuroscience top 5%
- Nuclear Receptors and Signaling
- Genetic Neurodegenerative Diseases

Papers in

Neurology 50
- Parkinson's Disease Mechanisms and Treatments 25
- Neurological disorders and treatments 22
- Botulinum Toxin and Related Neurological Disorders 22
- Parkinson's Disease and Spinal Disorders 4
Cellular and Molecular Neuroscience 9
- Genetic Neurodegenerative Diseases 6

Co-authors: Yasar Torres‐Yaghi (26 shared papers)John A. Butman (2 shared papers)Charbel Moussa (15 shared papers)Michaeline Hebron (14 shared papers)Jaeil Ahn (13 shared papers)Mark Hallett (2 shared papers)Barbara Wilmarth (9 shared papers)Abigail Lawler (6 shared papers)
Journals: Neurology (14 papers)Parkinsonism & Related Disorders (5 papers)Neurology and Therapy (4 papers)Toxicon (3 papers)Movement Disorders (2 papers)
Partner nations: United States Germany Greece

In The Last Decade

Fernando Pagán

70 papers receiving 1.7k citations

Peers

Countries citing papers authored by Fernando Pagán

Since Specialization

Citations

This map shows the geographic impact of Fernando Pagán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Pagán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Pagán more than expected).

Fields of papers citing papers by Fernando Pagán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Pagán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Pagán. The network helps show where Fernando Pagán may publish in the future.

Co-authors

The 25 scholars most cited alongside Fernando Pagán, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fernando Pagán Line = papers co-authored together Fernando Pagán links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies Journal of Parkinson s Disease ·Fernando Pagán, Michaeline Hebron, Ellen Valadez, Yasar Torres‐Yaghi, Xu Huang, Reversa Mills, Barbara Wilmarth, Hellen Howard, Connell Dunn, Alexis Carlson, Abigail Lawler, Sean Rogers, Ramsey Falconer, Jaeil Ahn, Zhaoxia Li, Charbel Moussa	2016	197
2	Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease JAMA Neurology ·Fernando Pagán, Michaeline Hebron, Barbara Wilmarth, Yasar Torres‐Yaghi, Abigail Lawler, Elizabeth Mundel, Nadia Yusuf, Nathan Starr, Muhammad Burhan Anjum, Joy Arellano, Helen Howard, Wangke Shi, Sanjana Mulki, Tarick Kurd-Misto, Sara Matar, Xiaoguang Liu, Jaeil Ahn, Charbel Moussa	2019	125
3	Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy Neurology ·Fernando Pagán, John A. Butman, James M. Dambrosia, Mark Hallett	2003	104
4	Involvement of Insula and Cingulate Cortices in Control and Suppression of Natural Urges Cerebral Cortex ·Alicja Lerner, Anto Bagić, Takashi Hanakawa, Eilis Boudreau, Fernando Pagán, Zoltán Mari, William Bara‐Jimenez, Murat Aksu, Susumu Satô, Dennis L. Murphy, Mark Hallett	2008	87
5	Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease Annals of Neurology ·Raymond Scott Turner, Michaeline Hebron, Abigail Lawler, Elizabeth Mundel, Nadia Yusuf, J. Nathan Starr, Muhammad Burhan Anjum, Fernando Pagán, Yasar Torres‐Yaghi, Wangke Shi, Sanjana Mulki, Dalila Ferrante, Sara Matar, Xiaoguang Liu, Giuseppe Esposito, Frank E. Berkowitz, Xiong Jiang, Jaeil Ahn, Charbel Moussa	2020	86
6	CXCR4 and CXCL12 Expression is Increased in the Nigro-Striatal System of Parkinson’s Disease Neurotoxicity Research ·Mika Shimoji, Fernando Pagán, Edward B. Healton, Italo Mocchetti	2009	84
7	Safety of MRI in patients with implanted deep brain stimulation devices NeuroImage ·Michele Tagliati, Joseph Jankovic, Fernando Pagán, Frandy Susatia, Ioannis U. Isaias, Michael S. Okun	2009	84
8	Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome Neurology ·Alicja Lerner, Anto Bagić, Eilis Boudreau, Takashi Hanakawa, Fernando Pagán, Zoltán Mari, William Bara‐Jimenez, Murat Aksu, Gaëtan Garraux, Janine M. Simmons, Susumu Satô, Dennis L. Murphy, Mark Hallett	2007	82
9	Improving outcomes through early diagnosis of Parkinson's disease. PubMed ·Fernando Pagán	2012	81
10	Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease Pharmacology Research & Perspectives ·Fernando Pagán, Michaeline Hebron, Barbara Wilmarth, Yasar Torres‐Yaghi, Abigail Lawler, Elizabeth Mundel, Nadia Yusuf, Nathan Starr, Joy Arellano, Helen Howard, Margo A. Peyton, Sara Matar, Xiaoguang Liu, Alan J. Fowler, Sorell L. Schwartz, Jaeil Ahn, Charbel Moussa	2019	80
11	SIAXI Neurology ·Wolfgang H. Jost, Andrzej Friedman, Olaf Michel, Christian Oehlwein, Jarosław Sławek, Andrzej Bogucki, Stanisław Ochudlo, Marta Banach, Fernando Pagán, Birgit Flatau‐Baqué, János Csikós, Claire J. Cairney, Andrew Blitzer	2019	73
12	Primary lateral sclerosis Neurology ·Ping Zhai, Fernando Pagán, Jeffrey Statland, John A. Butman, Mary Kay Floeter	2003	64
13	Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease Movement Disorders Clinical Practice ·Stuart Isaacson, Mark Lew, William G. Ondo, Jean Hubble, Thomas Clinch, Fernando Pagán	2016	55
14	Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo‐controlled trial Movement Disorders ·Daniel Weintraub, Robert A. Hauser, Jordan J. Elm, Fernando Pagán, Matthew D. Davis, Azhar Choudhry, (unknown)	2016	51
15	Protection from oxidation enhances the survival of cultured mesencephalic neurons Experimental Neurology ·Carol A. Colton, Fernando Pagán, Julie Snell, Joel S. Colton, Alex C. Cummins, Daniel L. Gilbert	1995	49
16	Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults JAMA Neurology ·Stuart Isaacson, William G. Ondo, Carlayne E. Jackson, Richard Trosch, Eric Molho, Fernando Pagán, Mark Lew, Khashayar Dashtipour, Thomas Clinch, Alberto J. Espay, (unknown)	2020	41
17	Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease Movement Disorders ·Fernando Pagán, Barbara Wilmarth, Yasar Torres‐Yaghi, Michaeline Hebron, Sanjana Mulki, Dalila Ferrante, Sara Matar, Jaeil Ahn, Charbel Moussa	2020	39
18	Sialorrhea in Parkinson’s Disease Toxins ·Jonathan Isaacson, Sanskruti Patel, Yasar Torres‐Yaghi, Fernando Pagán	2020	36
19	Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases Human Molecular Genetics ·Alan J. Fowler, Michaeline Hebron, Kaluvu Balaraman, Wangke Shi, Alexander A. Missner, Jonathan D. Greenzaid, Timothy L Chiu, Clementina J. Ullman, Ethan Weatherdon, Val Duka, Yasar Torres‐Yaghi, Fernando Pagán, Xiaoguang Liu, Habtom W. Ressom, Jaeil Ahn, Christian Wolf, Charbel Moussa	2020	26
20	Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks Parkinsonism & Related Disorders ·Wolfgang H. Jost, Andrzej Friedman, Olaf Michel, Christian Oehlwein, Jarosław Sławek, Andrzej Bogucki, Stanisław Ochudlo, Marta Banach, Fernando Pagán, Birgit Flatau‐Baqué, Ulrike Dorsch, János Csikós, Andrew Blitzer	2019	25

About Fernando Pagán

Fernando Pagán is a scholar working on Neurology, Cellular and Molecular Neuroscience, Molecular Biology, Oncology and Hematology, having authored 72 papers that have together received 1.7k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (25 papers), Neurological disorders and treatments (22 papers), Botulinum Toxin and Related Neurological Disorders (22 papers), Genetic Neurodegenerative Diseases (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers), Parkinson's Disease and Spinal Disorders (4 papers) and Pain Mechanisms and Treatments (3 papers). The work is most often cited by research in Neurology (982 citations), Neurology (183 citations), Cellular and Molecular Neuroscience (391 citations), Physiology (263 citations) and Cognitive Neuroscience (145 citations). Fernando Pagán has collaborated with scholars based in United States, Germany and Greece. Frequent co-authors include Yasar Torres‐Yaghi, John A. Butman, Charbel Moussa, Michaeline Hebron, Jaeil Ahn, Mark Hallett, Barbara Wilmarth, Abigail Lawler, James M. Dambrosia and Sara Matar. Their work appears in journals such as Neurology, Parkinsonism & Related Disorders, Neurology and Therapy, Toxicon and Movement Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Fernando Pagán

Impact in

Papers in i

In The Last Decade

Fernando Pagán

Peers

Countries citing papers authored by Fernando Pagán

Fields of papers citing papers by Fernando Pagán

All Works

About Fernando Pagán

Explore authors with similar magnitude of impact

Papers in